These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


201 related items for PubMed ID: 7979283

  • 1. Synergism between the antifungal agents amphotericin B and alkyl glycerol ethers.
    Haynes MP, Buckley HR, Higgins ML, Pieringer RA.
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1523-9. PubMed ID: 7979283
    [Abstract] [Full Text] [Related]

  • 2. Mode of action and synergistic effect of valinomycin and cereulide with amphotericin B against Candida albicans and Cryptococcus albidus.
    Makarasen A, Reukngam N, Khlaychan P, Chuysinuan P, Isobe M, Techasakul S.
    J Mycol Med; 2018 Mar; 28(1):112-121. PubMed ID: 29276078
    [Abstract] [Full Text] [Related]

  • 3. Synergistic effects of low doses of histatin 5 and its analogues on amphotericin B anti-mycotic activity.
    van't Hof W, Reijnders IM, Helmerhorst EJ, Walgreen-Weterings E, Simoons-Smit IM, Veerman EC, Amerongen AV.
    Antonie Van Leeuwenhoek; 2000 Aug; 78(2):163-9. PubMed ID: 11204768
    [Abstract] [Full Text] [Related]

  • 4. Itraconazole vs amphotericin B: in vitro comparative evaluation of the minimal inhibitory concentration (MIC) against clinically isolated yeasts.
    Lombardi G, Gramegna G, Cavanna C, Poma G, Marangoni E, Michelone G.
    Mycopathologia; 1989 Apr; 106(1):31-4. PubMed ID: 2549421
    [Abstract] [Full Text] [Related]

  • 5. The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug.
    Mesa-Arango AC, Trevijano-Contador N, Román E, Sánchez-Fresneda R, Casas C, Herrero E, Argüelles JC, Pla J, Cuenca-Estrella M, Zaragoza O.
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6627-38. PubMed ID: 25155595
    [Abstract] [Full Text] [Related]

  • 6. In-vitro activity of cilofungin (LY121019) in comparison with amphotericin B.
    Meunier F, Lambert C, Van der Auwera P.
    J Antimicrob Chemother; 1989 Sep; 24(3):325-31. PubMed ID: 2681118
    [Abstract] [Full Text] [Related]

  • 7. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and Candida spp.
    Rossi SA, de Oliveira HC, Agreda-Mellon D, Lucio J, Mendes-Giannini MJS, García-Cambero JP, Zaragoza O.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 31988099
    [Abstract] [Full Text] [Related]

  • 8. Synergism between penicillin G and the antimicrobial ether lipid, rac-1-dodecylglycerol, acting below its critical micelle concentration.
    Ved HS, Gustow E, Pieringer RA.
    Lipids; 1990 Feb 24; 25(2):119-21. PubMed ID: 2329923
    [Abstract] [Full Text] [Related]

  • 9. Lactoferrin Is Broadly Active against Yeasts and Highly Synergistic with Amphotericin B.
    Fernandes KE, Weeks K, Carter DA.
    Antimicrob Agents Chemother; 2020 Apr 21; 64(5):. PubMed ID: 32094132
    [Abstract] [Full Text] [Related]

  • 10. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F, Patel R, Mann PA, Mendrick CA, Norris CC, Hare R, Loebenberg D, Black TA, McNicholas PM.
    Antimicrob Agents Chemother; 2006 Jun 21; 50(6):2009-15. PubMed ID: 16723559
    [Abstract] [Full Text] [Related]

  • 11. Enhanced activity of antifungal drugs using natural phenolics against yeast strains of Candida and Cryptococcus.
    Faria NC, Kim JH, Gonçalves LA, Martins Mde L, Chan KL, Campbell BC.
    Lett Appl Microbiol; 2011 May 21; 52(5):506-13. PubMed ID: 21332761
    [Abstract] [Full Text] [Related]

  • 12. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G, Manzara S, Dettori G.
    Chemotherapy; 1991 May 21; 37(1):23-31. PubMed ID: 2013239
    [Abstract] [Full Text] [Related]

  • 13. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
    To WK, Fothergill AW, Rinaldi MG.
    J Clin Microbiol; 1995 Oct 21; 33(10):2660-4. PubMed ID: 8567901
    [Abstract] [Full Text] [Related]

  • 14. Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro.
    Franzot SP, Casadevall A.
    Antimicrob Agents Chemother; 1997 Feb 21; 41(2):331-6. PubMed ID: 9021188
    [Abstract] [Full Text] [Related]

  • 15. In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
    Carrillo-Muñoz AJ, Quindós G, Tur C, Ruesga MT, Miranda Y, del Valle O, Cossum PA, Wallace TL.
    J Antimicrob Chemother; 1999 Sep 21; 44(3):397-401. PubMed ID: 10511410
    [Abstract] [Full Text] [Related]

  • 16. Impact of iron chelators on growth and expression of iron-related genes of Cryptococcus species.
    Chayakulkeeree M, Tangkoskul T, Waywa D, Tiengrim S, Pati N, Thamlikitkul V.
    J Mycol Med; 2020 Apr 21; 30(1):100905. PubMed ID: 31706700
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species.
    Valentín A, Cantón E, Pemán J, Fernandez-Rivero ME, Tormo-Mas MA, Martínez JP.
    J Antimicrob Chemother; 2016 Dec 21; 71(12):3449-3452. PubMed ID: 27543657
    [Abstract] [Full Text] [Related]

  • 18. Synergistic fungicidal activity of the lipopeptide bacillomycin D with amphotericin B against pathogenic Candida species.
    Tabbene O, Di Grazia A, Azaiez S, Ben Slimene I, Elkahoui S, Alfeddy MN, Casciaro B, Luca V, Limam F, Mangoni ML.
    FEMS Yeast Res; 2015 Jun 21; 15(4):fov022. PubMed ID: 25956541
    [Abstract] [Full Text] [Related]

  • 19. Antifungal effect of Hevea brasiliensis latex with various fungi. Its synergistic action with amphotericin B against Candida albicans.
    Giordani R, Regli P, Buc J.
    Mycoses; 2002 Dec 21; 45(11-12):476-81. PubMed ID: 12472724
    [Abstract] [Full Text] [Related]

  • 20. Dynamic interaction between fluconazole and amphotericin B against Cryptococcus gattii.
    Santos JR, Gouveia LF, Taylor EL, Resende-Stoianoff MA, Pianetti GA, César IC, Santos DA.
    Antimicrob Agents Chemother; 2012 May 21; 56(5):2553-8. PubMed ID: 22290956
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.